FDA Grants Accelerated Approval To First Gene Therapy For Duchenne Muscular Dystrophy

June 23, 2023

MedPage Today (6/22, George) reports, “The FDA granted accelerated approval to delandistrogene moxeparvovec (Elevidys), the first gene therapy for Duchenne muscular dystrophy” (DMD), “the agency announced” in a June 22 news release on its website. This “a...